ReShape Lifesciences Inc (NASDAQ:RSLS)

0.531
Delayed Data
As of Apr 25
 -0.0591 / -10.02%
Today’s Change
0.28
Today|||52-Week Range
6.45
-64.12%
Year-to-Date
No recent news for ReShape Lifesciences Inc.

Today’s Trading

Previous close0.59
Today’s open0.59
Day’s range0.28 - 0.59
Volume338,661
Average volume (3 months)240,224
Market cap$47.7M
Data as of 3:56pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+87.45%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+169.40%
P/E ratioNM
Price/Sales1.58
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
AEMDAethlon Medical Inc+0.01+0.77%
CYTXCytori Therapeutics ...-0.01-3.85%
RVPRetractable Technolo...-0.03-3.38%
--Suda Pharmaceuticals...0.000.00%
Data as of 4:00pm ET, 04/25/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$786.7K
Annual profit (last year)-$23.4M
Net profit margin-2,969.62%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Dan W. Gladney
Senior VP-Operations &
Business Development
Peter M. Delange
Corporate headquarters
St. Paul, Minnesota

Forecasts